These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Epitranscriptional regulation of TGF-β pseudoreceptor BAMBI by m6A/YTHDF2 drives extrinsic radioresistance. Wang L; Si W; Yu X; Piffko A; Dou X; Ding X; Bugno J; Yang K; Wen C; Zhang L; Chen D; Huang X; Wang J; Arina A; Pitroda S; Chmura SJ; He C; Liang HL; Weichselbaum R J Clin Invest; 2023 Dec; 133(24):. PubMed ID: 38099498 [TBL] [Abstract][Full Text] [Related]
4. YTHDF2/m Zhang L; Dou X; Zheng Z; Ye C; Lu TX; Liang HL; Wang L; Weichselbaum RR; He C EMBO J; 2023 Aug; 42(15):e113126. PubMed ID: 37345898 [TBL] [Abstract][Full Text] [Related]
5. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m Chai RC; Chang YZ; Chang X; Pang B; An SY; Zhang KN; Chang YH; Jiang T; Wang YZ J Hematol Oncol; 2021 Jul; 14(1):109. PubMed ID: 34246306 [TBL] [Abstract][Full Text] [Related]
6. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397 [TBL] [Abstract][Full Text] [Related]
7. Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells. Lyu Z; Huang B; Zhang J; Qian Q; Pu X; Cui N; Ou Y; Li B; You Z; Lian M; Tang R; Chen W; Zhao Z; Hou J; Gershwin ME; Zhang H; Xia Q; Ma X J Autoimmun; 2023 Feb; 135():102993. PubMed ID: 36642058 [TBL] [Abstract][Full Text] [Related]
9. The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function. Mapperley C; van de Lagemaat LN; Lawson H; Tavosanis A; Paris J; Campos J; Wotherspoon D; Durko J; Sarapuu A; Choe J; Ivanova I; Krause DS; von Kriegsheim A; Much C; Morgan M; Gregory RI; Mead AJ; O'Carroll D; Kranc KR J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33156926 [TBL] [Abstract][Full Text] [Related]
10. YTHDF2 mediates LPS-induced osteoclastogenesis and inflammatory response via the NF-κB and MAPK signaling pathways. Fang C; He M; Li D; Xu Q Cell Signal; 2021 Sep; 85():110060. PubMed ID: 34089814 [TBL] [Abstract][Full Text] [Related]
11. YTHDF2 Regulates Macrophage Polarization through NF- Cai L; Li D; Feng Z; Gu X; Xu Q; Li Q Dis Markers; 2022; 2022():3153362. PubMed ID: 36277978 [TBL] [Abstract][Full Text] [Related]
12. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer. Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495 [TBL] [Abstract][Full Text] [Related]
13. HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling. Arkhypov I; Özbay Kurt FG; Bitsch R; Novak D; Petrova V; Lasser S; Hielscher T; Groth C; Lepper A; Hu X; Li W; Utikal J; Altevogt P; Umansky V J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36113897 [TBL] [Abstract][Full Text] [Related]
14. Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy. Zhou J; Liu M; Sun H; Feng Y; Xu L; Chan AWH; Tong JH; Wong J; Chong CCN; Lai PBS; Wang HK; Tsang SW; Goodwin T; Liu R; Huang L; Chen Z; Sung JJ; Chow KL; To KF; Cheng AS Gut; 2018 May; 67(5):931-944. PubMed ID: 28939663 [TBL] [Abstract][Full Text] [Related]
15. Neddylation pathway promotes myeloid-derived suppressor cell infiltration via NF-κB-mCXCL5 signaling in lung cancer. Zhou L; Lin X; Zhang L; Chen S; Chen J; Zhou Z; Tang A; Ruan J; Wang X; Chen B Int Immunopharmacol; 2022 Dec; 113(Pt A):109329. PubMed ID: 36252470 [TBL] [Abstract][Full Text] [Related]
16. Non-canonical NF-κB Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy. Hou Y; Liang H; Rao E; Zheng W; Huang X; Deng L; Zhang Y; Yu X; Xu M; Mauceri H; Arina A; Weichselbaum RR; Fu YX Immunity; 2018 Sep; 49(3):490-503.e4. PubMed ID: 30170810 [TBL] [Abstract][Full Text] [Related]
17. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8 Ma S; Sun B; Duan S; Han J; Barr T; Zhang J; Bissonnette MB; Kortylewski M; He C; Chen J; Caligiuri MA; Yu J Nat Immunol; 2023 Feb; 24(2):255-266. PubMed ID: 36658237 [TBL] [Abstract][Full Text] [Related]
18. Senolytics Cocktail Dasatinib and Quercetin Alleviate Human Umbilical Vein Endothelial Cell Senescence via the TRAF6-MAPK-NF-κB Axis in a YTHDF2-Dependent Manner. Fan T; Du Y; Zhang M; Zhu AR; Zhang J Gerontology; 2022; 68(8):920-934. PubMed ID: 35468611 [TBL] [Abstract][Full Text] [Related]
19. Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth. Tu SP; Jin H; Shi JD; Zhu LM; Suo Y; Lu G; Liu A; Wang TC; Yang CS Cancer Prev Res (Phila); 2012 Feb; 5(2):205-15. PubMed ID: 22030090 [TBL] [Abstract][Full Text] [Related]
20. The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity. Ma S; Yan J; Barr T; Zhang J; Chen Z; Wang LS; Sun JC; Chen J; Caligiuri MA; Yu J J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34160549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]